Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 6, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., executed stock options to acquire 86,398 shares at $5.01 and 7,396 shares at $11.53.
- Okupe then sold 98,635 shares of Class A Common Stock at an average price of $21.4247, with prices ranging from $21.14 to $21.725.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 10, 2023.
- Following these transactions, Okupe directly owns 146,839 shares of Class A Common Stock and holds options to purchase 953,445 additional shares.
- The stock options vest over time, with portions vesting monthly, subject to continuous service.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports transactions under a pre-arranged plan. There's no indication of positive or negative sentiment towards the company's prospects.
Positives
- The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.
Risks
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors.
Future Outlook
The document does not contain specific forward-looking statements, but it indicates ongoing vesting of stock options and potential future transactions under the 10b5-1 plan.
Industry Context
Insider transactions are common in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid accusations of insider trading. Monitoring these transactions provides insights into management's perspective on the company's value.
Stakeholder Impact
- Shareholders may monitor insider transactions for insights into management's confidence in the company.
- Employees holding stock options may be interested in the vesting schedules and exercise prices.
Key Dates
| Date | Description |
|---|---|
| January 24, 2022 | Vesting Commencement Date for some stock options. |
| May 10, 2023 | Date the Rule 10b5-1 trading plan was adopted. |
| April 1, 2023 | Monthly vesting of options begins. |
| June 6, 2024 | Date of stock option exercises and share sales. |
| June 10, 2024 | Date of the SEC Form 4 filing. |
| February 23, 2032 | Expiration date for some stock options. |
| March 1, 2033 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.